Supplements

Supplements currently available include:

Clopidogrel in the modern management of atherothrombosis - Supplement available on request
Volume 14, Supplement 5, November-December 2007

Direct renin inhibition with aliskiren – a new option in treating hypertension
Volume 14, Supplement 4, November-December 2007

The debate for and against. Should cholesterol targets be 4 and 2 mmol/L?
Volume 14, Supplement 2, September-October 2007

Optimising global risk reduction: insights from REACH
Volume 14, Supplement 3, September-October 2007

Best practice principles for cholesterol lowering
Volume 14, Supplement 1, May-June 2007

ACE inhibition in coronary artery disease
Volume 13, Supplement 2, May-June 2006

Switching statins: what are the issues and implications?
Volume 13, Supplement 1, March-April 2006

Phosphodiesterase type 5 (PDE5) inhibitors: looking beyond erectile dysfunction
Volume 10, Supplement 4, September-October 2003

Myocardial perfusion scintigraphy – the implications of the NICE recommendations: a round table discussion. National Heart and Lung Institute, London
Volume 12, Supplement 2, July-August 2005

This House believes that the UK healthcare system may be failing as many as 50% of patients with hyperlipidaemia by not reducing their cholesterol to effective levels: a debate
Volume 12, Supplement 1, May-June 2005

Dual inhibition of cholesterol absorption and cholesterol synthesis
Volume 11, Supplement 3, March-April 2004

Supplement to Acute & Interventional Cardiology
Primary angioplasty for acute myocardial infarction in the UK: now is the time!
Volume 11, Supplement 1, March 2004

Improved cardiovascular risk reduction: the evidence for raising HDL cholesterol
Volume 11, Supplement 2, January-February 2004

Diet and heart health symposium II
Volume 11, Supplement 1, January-February 2004

Reality versus guidelines: the challenge of achieving blood pressure targets
Volume 10, Supplement 3, May-June 2003

Diet and heart health: emerging evidence
Volume 10, Supplement 1, January-February 2003

Socratic dialogue: the future management of hyperlipidaemia
Volume 10, Supplement 2, January-February 2003

Optimising antiplatelet therapy in high-risk cardiovascular patients: the emerging role of clopidogrel
Volume 9, Supplement 8, November 2002

Early thrombolysis - the realities and the practicalities
Volume 9, Supplement 7, September 2002

The cholesterol management debates
Volume 9, Supplement 5, July-August 2002

The Impact of Nicorandil in Angina (IONA) study
Volume 9, Supplement 6, July-August 2002

Taking vascular disease beyond convention
Volume 9, Supplement 4, June 2002

Joint British Societies implementation group for the prevention of cardiovascular disease
Volume 9, Supplement 3, April 2002

Transradial cardiac procedures - a UK perspective
Volume 9, Supplement 2, March 2002

Angiotensin II on trial
Volume 9, Supplement 1, February 2002